drugset / Trial / NCT01675115
Efficacy of BNG-1 to Treat Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to investigate the efficacy and safety of BNG-1 in patients with ischemic stroke. The efficacy assessment will be based on the functional outcome while the safety will be reviewed by the adverse events and laboratory examinations.
Timeline
- Start
- 2012-08
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BNG-1 | Unknown | 3 g | — |
| Comparator | Aspirin | Small molecule | 100 mg | — |